Risa Suzuki received her Ph.D. at the University of Tokyo, Japan, in 2015, focusing on protein engineering and construction of a universal screening system for elucidating enzyme functions involved in drug metabolism. From 2015 to 2017 she worked as a postdoctoral research associate at Nagoya University and Tokyo Institute of Technology, working on a JST funded ALCA project on microbe reaction engineering. In 2017, she was employed as a project assistant professor in the School of Medicine at the University of Tokyo. Her research interests and expertise encompass the developing and manufacturing of biopharmaceuticals and crystal structure analysis of proteins. She now works for Shimadzu Corporation in Kyoto, Japan, as a member of the Healthcare Solution Unit in the Solutions COE.